Can Adipose Tissue Browning Become a New Frontier in Cardiometabolic Prevention?
Atherosclerosis posted on LinkedIn:
”Can adipose tissue browning become a new frontier in cardiometabolic prevention?
Emerging research is uncovering how browning of white adipose tissue (AT) – the conversion to a more metabolically active, thermogenic phenotype – could improve both metabolic and cardiovascular health.
- Pro-inflammatory pathways (NLRP3, TLR4, NF-κB) inhibit browning
- Anti-inflammatory signals (IL-4, IL-13, M2 macrophages) promote it, enhancing insulin sensitivity and glucose tolerance
- Mitochondrial effectors – UCP-1 and PGC1-α – are key drivers of thermogenesis
- Experimental interventions (ASK-1 knockout, nitrate, melatonin) improved endothelial function, atherosclerosis, and liver steatosis
While evidence is still largely preclinical, these findings suggest that targeting adipose tissue inflammation and mitochondrial function could open new therapeutic avenues for atherosclerotic cardiovascular disease.
Could “browning” therapies become part of the next generation of cardiometabolic treatments?”
Read the full article here.
Title: Molecular mechanisms linking adipose tissue browning to reduced cardiovascular risk
Authors: Ana Checa-Rosa, Luis D’Marco

Stay updated with Hemostasis Today.
-
Jul 12, 2026, 06:12Precision in Antithrombotic Therapy at ISTH 2026 – The Lancet Haematology
-
Jul 11, 2026, 23:36Emmanuel J Favaloro: A Fresh Perspective on the Manual Tilt Tube Method for PT and INR Determination
-
Jul 11, 2026, 21:44Timos Papagatsias: From Promising Concepts to Clinical Differentiation at ISTH 2026
-
Jul 11, 2026, 21:43Sharing New Research in Hemophilia at ISTH 2026 – Novo Nordisk Medical US
-
Jul 11, 2026, 21:41Bianca Constantin: Don’t Miss the ISTH Early Career Committee Activities
-
Jul 11, 2026, 21:38Fateme Babaha: Don’t Miss Your Favorite ISTH 2026 Sessions
-
Jul 11, 2026, 21:11Farjah Algahtani: Learning, Sharing, and Collaborating at ISTH 2026
-
Jul 11, 2026, 19:56Louise St. Germain Bannon: A Fantastic Start to ISTH 2026 and the Future of Thrombosis Research
-
Jul 11, 2026, 19:38Lynn Kloeckner: Recognizing Kirsten Lacine’s Impact on the Stroke Survivor Journey